Mike Gerometta

Head of CMC Development at Opthea - South Yarra, VIC, AU

Mike Gerometta's Contact Details
HQ
61-3-9826-0399
Location
Brisbane,Queensland,Australia
Company
Opthea
Mike Gerometta's Company Details
Opthea logo, Opthea contact details

Opthea

South Yarra, VIC, AU • 20 - 49 Employees
BioTech/Drugs

Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap', to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments. Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life. Enquiries can be directed to: info@opthea.com

Ophthalmological drug development
Details about Opthea
Frequently Asked Questions about Mike Gerometta
Mike Gerometta currently works for Opthea.
Mike Gerometta's role at Opthea is Head of CMC Development.
Mike Gerometta's email address is ***@opthea.com. To view Mike Gerometta's full email address, please signup to ConnectPlex.
Mike Gerometta works in the Research industry.
Mike Gerometta's colleagues at Opthea are Judy Robertson, Mark Oneill, Megan Baldwin, Annette Leahy, Clare Price, Richard Chadwick and others.
Mike Gerometta's phone number is 61-3-9826-0399
See more information about Mike Gerometta